# Chatham Lodging Trust: financial statements, quarterly

CLDT · NYSE · CIK 1476045 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cldt.md) · [Financials](/companies/cldt/financials.md) · [Filings](/companies/cldt/filings.md) · [Insiders](/companies/cldt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cldt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [86.7](/filings/0001476045-24-000049.md) | [72.3 d](/filings/0001476045-25-000011.md) | [68.4](/filings/0001476045-24-000035.md) | [86.5](/filings/0001476045-24-000045.md) | [87.2](/filings/0001476045-24-000049.md) | [75.1 d](/filings/0001476045-25-000011.md) | [68.6](/filings/0001437749-26-015470.md) | [80.3](/filings/0001437749-26-025638.md) | [78.4](/filings/0001437749-25-033297.md) | [67.7 d](/filings/0001437749-26-006103.md) | [67.5](/filings/0001437749-26-015470.md) | [87.8](/filings/0001437749-26-025638.md) |
| Cost of revenue | $m | [47.7](/filings/0001476045-24-000049.md) | [43.9 d](/filings/0001476045-25-000011.md) | [41.8](/filings/0001476045-24-000035.md) | [46.6](/filings/0001476045-24-000045.md) | [48.2](/filings/0001476045-24-000049.md) | [44.5 d](/filings/0001476045-25-000011.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | [4.6](/filings/0001437749-25-014749.md) | [4.6](/filings/0001437749-25-025025.md) | [4.4](/filings/0001437749-25-033297.md) | [4.8 d](/filings/0001437749-26-006103.md) | [4.6](/filings/0001437749-26-015470.md) | [4.0](/filings/0001437749-26-025638.md) | [4.1](/filings/0001437749-25-033297.md) | [3.8 d](/filings/0001437749-26-006103.md) | [4.6](/filings/0001437749-26-015470.md) | [4.6](/filings/0001437749-26-025638.md) |
| Operating income | $m | [13.9](/filings/0001476045-24-000049.md) | [(2.8) d](/filings/0001437749-26-006103.md) | [1.0](/filings/0001437749-25-014749.md) | [14.1](/filings/0001437749-25-025025.md) | [12.5](/filings/0001437749-25-033297.md) | [5.6 d](/filings/0001437749-26-006103.md) | [8.3](/filings/0001437749-26-015470.md) | [11.9](/filings/0001437749-26-025638.md) | [9.9](/filings/0001437749-25-033297.md) | [10.8 d](/filings/0001437749-26-006103.md) | [1.6](/filings/0001437749-26-015470.md) | [15.4](/filings/0001437749-26-025638.md) |
| Interest expense | $m | [6.8](/filings/0001476045-23-000066.md) | [7.4 d](/filings/0001476045-24-000019.md) | [7.3](/filings/0001476045-24-000035.md) | [7.7](/filings/0001437749-25-025025.md) | [8.3](/filings/0001437749-25-033297.md) | [7.6 d](/filings/0001437749-26-006103.md) | [6.9](/filings/0001437749-26-015470.md) | [6.4](/filings/0001437749-26-025638.md) | [6.2](/filings/0001437749-25-033297.md) | [6.2 d](/filings/0001437749-26-006103.md) | [6.2](/filings/0001437749-26-015470.md) | [6.9](/filings/0001437749-26-025638.md) |
| Income tax | $m | [0.0](/filings/0001476045-24-000049.md) | [0.0 d](/filings/0001437749-26-006103.md) | [0.0](/filings/0001437749-25-014749.md) | [0.0](/filings/0001437749-25-025025.md) | [0.0](/filings/0001437749-25-033297.md) | [0.0 d](/filings/0001437749-26-006103.md) | [0.0](/filings/0001437749-26-015470.md) | [0.0](/filings/0001437749-26-025638.md) | [0.0](/filings/0001437749-26-006103.md) | [0.0 d](/filings/0001437749-26-006103.md) | [0.1](/filings/0001437749-26-015470.md) | [0.1](/filings/0001437749-26-025638.md) |
| Net income | $m | [7.3](/filings/0001476045-24-000049.md) | [(9.0) d](/filings/0001437749-26-006103.md) | [(5.2)](/filings/0001437749-25-014749.md) | [6.8](/filings/0001437749-25-025025.md) | [4.3](/filings/0001437749-25-033297.md) | [(1.7) d](/filings/0001437749-26-006103.md) | [1.5](/filings/0001437749-26-015470.md) | [5.4](/filings/0001437749-26-025638.md) | [3.5](/filings/0001437749-25-033297.md) | [4.6 d](/filings/0001437749-26-006103.md) | [(4.3)](/filings/0001437749-26-015470.md) | [8.2](/filings/0001437749-26-025638.md) |
| Diluted EPS | $ per share | [0.11](/filings/0001476045-24-000049.md) | not reported | [(0.15)](/filings/0001437749-25-014749.md) | [0.10](/filings/0001437749-25-025025.md) | [0.05](/filings/0001437749-25-033297.md) | not reported | [(0.01)](/filings/0001437749-26-015470.md) | [0.07](/filings/0001437749-26-025638.md) | [0.03](/filings/0001437749-25-033297.md) | not reported | [(0.13)](/filings/0001437749-26-015470.md) | [0.13](/filings/0001437749-26-025638.md) |
| Basic EPS | $ per share | [0.11](/filings/0001476045-24-000049.md) | not reported | [(0.15)](/filings/0001437749-25-014749.md) | [0.10](/filings/0001437749-25-025025.md) | [0.05](/filings/0001437749-25-033297.md) | not reported | [(0.01)](/filings/0001437749-26-015470.md) | [0.07](/filings/0001437749-26-025638.md) | [0.03](/filings/0001437749-25-033297.md) | not reported | [(0.13)](/filings/0001437749-26-015470.md) | [0.13](/filings/0001437749-26-025638.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | period not labelled (2025-03-01) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [68.1](/filings/0001476045-25-000011.md) | [72.3](/filings/0001476045-24-000035.md) | [10.6](/filings/0001476045-24-000045.md) | [19.3](/filings/0001476045-24-000049.md) | [20.2](/filings/0001437749-26-006103.md) | not reported | [18.6](/filings/0001437749-25-014749.md) | [17.2](/filings/0001437749-25-025025.md) | [13.2](/filings/0001437749-25-033297.md) | [24.4](/filings/0001437749-26-025638.md) | [13.7](/filings/0001437749-26-015470.md) | [11.3](/filings/0001437749-26-025638.md) |
| Total assets | $m | [1,344](/filings/0001476045-25-000011.md) | [1,333](/filings/0001476045-24-000035.md) | [1,302](/filings/0001476045-24-000045.md) | [1,295](/filings/0001476045-24-000049.md) | [1,255](/filings/0001437749-26-006103.md) | not reported | [1,226](/filings/0001437749-25-014749.md) | [1,194](/filings/0001437749-25-025025.md) | [1,183](/filings/0001437749-25-033297.md) | [1,170](/filings/0001437749-26-025638.md) | [1,243](/filings/0001437749-26-015470.md) | [1,234](/filings/0001437749-26-025638.md) |
| Total liabilities | $m | [540](/filings/0001476045-25-000011.md) | [538](/filings/0001476045-24-000035.md) | [505](/filings/0001476045-24-000045.md) | [497](/filings/0001476045-24-000049.md) | [463](/filings/0001437749-26-006103.md) | not reported | [437](/filings/0001437749-25-014749.md) | [405](/filings/0001437749-25-025025.md) | [397](/filings/0001437749-25-033297.md) | [392](/filings/0001437749-26-025638.md) | [481](/filings/0001437749-26-015470.md) | [472](/filings/0001437749-26-025638.md) |
| Long-term debt | $m | [486](/filings/0001476045-24-000019.md) | not reported | not reported | not reported | [407](/filings/0001437749-26-006103.md) | not reported | [381](/filings/0001437749-25-014749.md) | [351](/filings/0001437749-25-025025.md) | [339](/filings/0001437749-25-033297.md) | [339](/filings/0001437749-26-025638.md) | [424](/filings/0001437749-26-015470.md) | [414](/filings/0001437749-26-025638.md) |
| Shareholders' equity | $m | [776](/filings/0001476045-25-000011.md) | [765](/filings/0001476045-24-000035.md) | [766](/filings/0001476045-24-000045.md) | [765](/filings/0001476045-24-000049.md) | [758](/filings/0001437749-26-006103.md) | [789](/filings/0001437749-26-015470.md) | [755](/filings/0001437749-25-014749.md) | [754](/filings/0001437749-25-025025.md) | [749](/filings/0001437749-25-033297.md) | [741](/filings/0001437749-26-025638.md) | [723](/filings/0001437749-26-015470.md) | [722](/filings/0001437749-26-025638.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [33.6 d](/filings/0001476045-24-000049.md) | [10.1 d](/filings/0001437749-26-006103.md) | [6.9](/filings/0001437749-25-014749.md) | [25.2 d](/filings/0001437749-25-025025.md) | [28.8 d](/filings/0001437749-25-033297.md) | [12.9 d](/filings/0001437749-26-006103.md) | [4.2](/filings/0001437749-26-015470.md) | [22.1 d](/filings/0001437749-26-025638.md) | [25.6 d](/filings/0001437749-25-033297.md) | [12.3 d](/filings/0001437749-26-006103.md) | [13.3](/filings/0001437749-26-015470.md) | [25.6 d](/filings/0001437749-26-025638.md) |
| Dividends paid | $m | [3.6 d](/filings/0001476045-24-000049.md) | [3.6 d](/filings/0001437749-26-006103.md) | [3.6](/filings/0001437749-25-014749.md) | [3.6 d](/filings/0001437749-25-025025.md) | [3.6 d](/filings/0001437749-25-033297.md) | [3.6 d](/filings/0001437749-26-006103.md) | [3.7](/filings/0001437749-26-015470.md) | [4.7 d](/filings/0001437749-26-025638.md) | [4.7 d](/filings/0001437749-25-033297.md) | [4.6 d](/filings/0001437749-26-006103.md) | [4.5](/filings/0001437749-26-015470.md) | [5.0 d](/filings/0001437749-26-025638.md) |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0001437749-25-014749.md) | [0.0 d](/filings/0001437749-25-025025.md) | [0.0 d](/filings/0001437749-25-033297.md) | [0.0 d](/filings/0001437749-26-006103.md) | [0.0](/filings/0001437749-26-015470.md) | [0.1 d](/filings/0001437749-26-025638.md) | [1.8 d](/filings/0001437749-25-033297.md) | [7.0 d](/filings/0001437749-26-006103.md) | [6.6](/filings/0001437749-26-015470.md) | [2.8 d](/filings/0001437749-26-025638.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [49.1](/filings/0001476045-23-000066.md) | [48.8](/filings/0001476045-24-000035.md) | [49.0](/filings/0001476045-24-000045.md) | [49.0](/filings/0001476045-24-000049.md) | [48.9](/filings/0001437749-25-014749.md) | [49.0](/filings/0001437749-25-025025.md) | [49.1](/filings/0001437749-25-033297.md) | [49.0](/filings/0001437749-26-015470.md) | [49.6](/filings/0001437749-26-025638.md) | [49.6](/filings/0001437749-25-033297.md) | [47.3](/filings/0001437749-26-015470.md) | [47.9](/filings/0001437749-26-025638.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 46,565,614 at 2026-08-04, from the cover of the [10-Q filed 2026-08-04](/filings/0001437749-26-025638.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.